Patent application number | Description | Published |
20090318555 | Treatment of Vertigo with Acetyl-L-Leucine - The use of acetyl-L-leucine and the pharmaceutically acceptable salts of same for the manufacture of a medicament for the treatment of vertigo and other balance disorders. Advantageously, the acetyl-L-leucine is a 100% mixture. | 12-24-2009 |
20100063276 | USE OF 10-[(3R)-1-AZABICYCLO[2.2.2]OCT-3-YLMETHYL]-10H-PHENOTHIAZINE FOR THE PREPARATION OF A DRUG HAVING A SELECTIVE INHIBITION OF MUSCARINIC M1, M2, AND M3 RECEPTORS - This invention relates to the use of 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine as well as its pharmaceutically acceptable salts for the preparation of a drug having the particularity of treating or preventing urinary incontinence, by local and/or oral route. | 03-11-2010 |
20100273752 | MEQUITAZINE FOR TREATING OR PREVENTING PATHOLOGIES INVOLVING HISTAMINE H4 RECEPTORS - The present application relates to the use of 10-[(3R)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine, 10-[(3S)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine or 10-[(3R,3S)-1-azabicyclo[2.2.2]oct-3-ylmethyl]-10H-phenothiazine, or a pharmaceutically acceptable salt thereof, to prepare a drug to prevent or treat pathologies involving histamine H4 receptor. | 10-28-2010 |
20110071226 | EMOLLIENT COMPOSITION - The invention relates to an emollient composition for topical use that comprises a combination of glycerol, Vaseline and liquid paraffin as an active principle, in the form of an oil-in-water or water-in-oil emulsion. The invention also relates to: the use thereof for preparing a drug for treating dry skin conditions associated with certain dermatoses such as atopic dermatitis, ichthyosis conditions and psoriasis; the use thereof for preparing a drug for treating small superficial burns; and the use thereof for preparing a drug for preventing and/or treating and/or reducing the frequency and intensity of eczema attacks observed in patients suffering from atopic dermatitis. | 03-24-2011 |
Patent application number | Description | Published |
20090028869 | DIAGNOSIS AND TREATMENT OF ALZHEIMER'S AND OTHER NEURODEMENTING DISEASES - Isolated, monoclonal, human, anti-β-amyloid antibodies are provided which bind to dimeric forms of Ab with higher affinity than to monomeric forms of Ab and when bound to an Aβ polypeptide comprising Aβ(21-37) shield Aβ(21-37) from proteolytic digestion. The antibodies were shown to inhibit fibril formation and reduce plaque size in vivo and to not bind brain vessel walls. Accordingly, the antibodies are useful in human and veterinary medicine for the treatment and prophylaxis of Alzheimer's disease and other neurodementing diseases. Methods of detecting or measuring the progression of a neurodementing disease also are provided. | 01-29-2009 |
20120039897 | METHOD OF TREATMENT OF NEURODEMENTING DISEASES USING ISOLATED, MONOCLONAL, HUMAN, ANTI-B-AMYLOID ANTIBODY - Isolated, monoclonal, human, anti-β-amyloid antibodies are provided which bind to dimeric forms of Ab with higher affinity than to monomeric forms of Ab and when bound to an Aβ polypeptide comprising Aβ(21-37) shield Aβ(21-37) from proteolytic digestion. The antibodies were shown to inhibit fibril formulation and reduce plaque size in vivo and to not bind brain vessel walls. Accordingly, the antibodies are useful in human and veterinary medicine for the treatment and prophylaxis of Alzheimer's disease and other neurodementing diseases. Methods of detecting or measuring the progression of a neurodementing disease also are provided. | 02-16-2012 |
20120040382 | METHOD OF DETECTING PROGRESSION OF A NEURODEMENTING DISEASE - Isolated, monoclonal, human, anti-β-amyloid antibodies are provided which bind to dimeric forms of Ab with higher affinity than to monomeric forms of Ab and when bound to an Aβ polypeptide comprising Aβ(21-37) shield Aβ(21-37) from proteolytic digestion. The antibodies were shown to inhibit fibril formation and reduce plaque size in vivo and to not bind brain vessel walls. Accordingly, the antibodies are useful in human and veterinary medicine for the treatment and prophylaxis of Alzheimer's disease and other neurodementing diseases. Methods of detecting or measuring the progression of a neurodementing disease also are provided. | 02-16-2012 |
Patent application number | Description | Published |
20140050992 | COMPOSITE MATERIALS FOR LITHIUM-SULFUR BATTERIES - The present invention relates to sulfur-carbon composite materials comprising | 02-20-2014 |
20150380263 | CHEMICAL-MECHANICAL POLISHING COMPOSITIONS COMPRISING ONE OR MORE POLYMERS SELECTED FROM THE GROUP CONSISTING OF N-VINYL-HOMOPOLYMERS AND N-VINYL COPOLYMERS - Described is a chemical-mechanical polishing (CMP) composition comprising the following components: (A) surface modified silica particles having a negative zeta potential of −15 mV or below at a pH in the range of from 2 to 6 (B) one or more polymers selected from the group consisting of N-vinyl-homopolymers and N-vinyl copolymers (C) water (D) optionally one or more further constituents, wherein the pH of the composition is in the range of from 2 to 6. | 12-31-2015 |
20160068712 | CHEMICAL-MECHANICAL POLISHING COMPOSITIONS COMPRISING POLYETHYLENE IMINE - Described is a chemical-mechanical polishing (CMP) composition comprising the following components: (A) surface modified silica particles having a negative zeta potential of −15 mV or below at a pH in the range of from 2 to 6 (B) one or more polyethylene imines (C) water (D) optionally one or more further constituents, wherein the pH of the composition is in the range of from 2 to 6. | 03-10-2016 |
20160096979 | USE OF A CHEMICAL-MECHANICAL POLISHING (CMP) COMPOSITION FOR POLISHING A SUBSTRATE OR LAYER CONTAINING AT LEAST ONE III-V MATERIAL - Described is a use of a chemical-mechanical polishing (CMP) composition for polishing a substrate or layer containing one or more lll-V materials, wherein the chemical-mechanical polishing (CMP) composition comprises the following components: (A) surface modified silica particles having a negative zeta potential of −15 mV or below at a pH in the range of from 2 to 6 (B) one or more constituents selected from the group consisting of (i) substituted and unsubstituted triazoles not having an aromatic ring annealed to the triazol ring, (ii) benzimidazole, (iii) chelating agents selected from the group consisting of amino acids with two or more carboxyl groups, aliphatic carboxylic acids, and the respective salts thereof, and (iv) homopolymers and copolymers of acrylic acid, and the respective salts thereof, (C) water (D) optionally one or more further constituents, wherein the pH of the composition is in the range of from 2 to 6. | 04-07-2016 |
Patent application number | Description | Published |
20100123080 | PROCESS AND SYSTEM FOR THE NONDESTRUCTIVE QUALITY DETERMINATION OF A WELD SEAM, AND A WELDING DEVICE - A process for the non-destructive determination of the quality of a weld seam, the process steps comprising: providing a first and a second component; connecting the first and second components by a weld seam produced by a welding operation; and measuring a surface temperature of the weld seam and surface temperatures of areas of the first and second components adjacent to the weld seam that were heated by the welding operation. A system for carrying out the process for the non-destructive determination of the quality of a weld seam, the system comprising: a measuring device, an analyzing unit, and a welding device. | 05-20-2010 |
20110314799 | HYDRAULICALLY ACTIVATED EXHAUST FLAP - A flap arrangement in an exhaust track of a motor vehicle includes an exhaust flap and a slave cylinder for controlling an operative position of the exhaust flap. The slave cylinder is fluidly connected to a master cylinder by a hydraulic line containing a hydraulic fluid in the form of liquid metal. The movement of the master cylinder is thus transmitted via the liquid metal to the slave cylinder. A mechanical coupling of the slave cylinder with the exhaust flap moves the exhaust flap to a respective operative position. | 12-29-2011 |
20120151747 | PROCESS FOR PRODUCING OF A THERMOELECTRIC GENERATOR APPLICABLE IN AN EXHAUST LINE OF A MOTOR VEHICLE - A method for producing a thermoelectric generator configured to be used in an exhaust system of a motor vehicle. The thermoelectric generator includes a plurality of tubular thermoelectric modules arranged in a housing and including external pipes, internal pipes, p-doped and n-doped thermoelectric elements, and external rings. The thermoelectric modules are separated from one another on a face side by pipe bottoms. The method steps include connecting, by a gas-tight connection, the external pipes with the housing and the pipe bottoms; applying an electrically insulating coating onto inside surface of the external pipes; sliding the internal pipes including the p-doped and n-doped thermoelectric elements, and the external rings into the external pipes; shrinking the external pipes and fitting the external pipes into the internal pipes. | 06-21-2012 |
20120151938 | HEAT EXCHANGER - A heat exchanger for installation in a motor vehicle includes a cooling channel, a heating channel, and heat pipes to thermally couple the cooling channel with the heating channel. A thermoelectrical generator is arranged on a cold side of at least one of the heat pipes and coupled with the heat pipe by a material joint. The material joint is realized by a liquid metal. | 06-21-2012 |
20120180990 | HEAT EXCHANGER - A heat exchanger includes at least two adjacent heat exchanging tubes, each having equilateral triangular cross section. Hot gas flows through the heat exchanging tubes and coolant flows over the heat exchanging tubes. The heat exchanging tubes form a tube bundle of polygonal cross section and have two tube walls arranged in parallel side-by-side relation at a distance to one another. | 07-19-2012 |